cro.directory
← Compare landing

Aurigene Pharmaceutical Services Limited vs PozeSCAF Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aurigeneservices/pozescaf-discovery-solutions

CategoryAurigene Pharmaceutical Services LimitedPozeSCAF Inc.
Listed sitebothcro
SummaryIntegrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.
Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
  • Computational & In-Silico Drug Discovery
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Discovery Research
Modalities
  • Small Molecule
  • Biologics (Other)
  • Peptide
  • Small Molecule
  • Peptide
  • Antibody-Drug Conjugate (ADC)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Manufacturing - India, India
  • Manufacturing - UK, United Kingdom
  • Manufacturing - Mexico, Mexico
Data not yet provided.
Certifications
  • FDA · Identifier: 16 US FDA-inspected cGMP facilities
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.